Salta al contenuto principale
Passa alla visualizzazione normale.

FRANCESCO CAPPELLO

Plausible role of estrogens in pathogenesis, progression and therapy of lung cancer

  • Autori: Musial C.; Zaucha R.; Kuban-Jankowska A.; Konieczna L.; Belka M.; Gammazza A.M.; Baczek T.; Cappello F.; Wozniak M.; Gorska-Ponikowska M.
  • Anno di pubblicazione: 2021
  • Tipologia: Review essay (rassegna critica)
  • OA Link: http://hdl.handle.net/10447/528324

Abstract

Malignant neoplasms are among the most common diseases and are responsible for the majority of deaths in the developed world. In contrast to men, available data show a clear upward trend in the incidence of lung cancer in women, making it almost as prevalent as breast cancer. Women might be more susceptible to the carcinogenic effect of tobacco smoke than men. Furthermore, available data indicate a much more frequent mutation of the tumor suppressor genep53 in non-small cell lung cancer (NSCLC) female patients compared to males. Another important factor, however, might lie in the female sex hormones, whose mitogenic or carcinogenic effect is well known. Epidemiologic data show a correlation between hormone replacement therapy (HRT) or oral contraceptives (OCs), and increased mortality rates due to the increased incidence of malignant tumors, including lung cancer. Interestingly, two types of estrogen receptors have been detected in lung cancer cells: ERα and ERβ. The presence of ERα has been detected in tissues and non-small-cell lung carcinoma (NSCLC) cell lines. In contrast, overexpression of ERβ is a prognostic marker in NSCLC. Herein, we summarize the current knowledge on the role of estrogens in the etiopathogenesis of lung cancer, as well as biological, hormonal and genetic sex-related differences in this neoplasm.